SLC13A5 and osteoporosis: This observation may suggest that the effect on osteoporosis is mediated through SLC13A5 and citrate uptake by the relevant cells independently of actions on plasma citrate levels, or that plasma citrate is a heterogeneous trait that is affected through several distinct pathways, and that at least some of these may be beneficial for bones.